Nurix Therapeutics (NRIX) Current Leases: 2021-2025
Historic Current Leases for Nurix Therapeutics (NRIX) over the last 4 years, with Aug 2025 value amounting to $3.8 million.
- Nurix Therapeutics' Current Leases fell 42.15% to $3.8 million in Q3 2025 from the same period last year, while for Aug 2025 it was $3.8 million, marking a year-over-year decrease of 42.15%. This contributed to the annual value of $8.0 million for FY2024, which is 7.01% up from last year.
- Per Nurix Therapeutics' latest filing, its Current Leases stood at $3.8 million for Q3 2025, which was down 27.58% from $5.2 million recorded in Q2 2025.
- Nurix Therapeutics' Current Leases' 5-year high stood at $8.0 million during Q4 2024, with a 5-year trough of $3.8 million in Q3 2025.
- In the last 3 years, Nurix Therapeutics' Current Leases had a median value of $6.6 million in 2024 and averaged $6.3 million.
- Its Current Leases has fluctuated over the past 5 years, first soared by 43.75% in 2022, then tumbled by 42.15% in 2025.
- Quarterly analysis of 5 years shows Nurix Therapeutics' Current Leases stood at $3.8 million in 2021, then skyrocketed by 43.75% to $5.5 million in 2022, then soared by 35.42% to $7.5 million in 2023, then grew by 7.01% to $8.0 million in 2024, then crashed by 42.15% to $3.8 million in 2025.
- Its last three reported values are $3.8 million in Q3 2025, $5.2 million for Q2 2025, and $6.6 million during Q1 2025.